Vanessa Vankerckhoven has been CEO and founding partner of Novosanis, a spin-off of the University of Antwerp specialised in medical devices, since 2013. She is a passionate entrepreneur who is experienced in raising seed capital and subsidies.
Before starting Novosanis she was Research and Innovation Manager of the Institute for Vaccinations and Infectious Diseases (University of Antwerp). She began her career in 2000 at the Laboratory for Medical Microbiology (University of Antwerp).
Vanessa Vankerckhoven holds a doctorate in Medical Sciences (University of Antwerp) and has a special interest in infectious diseases, medical devices, diagnostics, microbiology and vaccinology.